المؤلفون: Pierpaolo Pastina, Pierpaolo Correale, Rocco Giannicola, Cesare Guida, Amalia Luce, Aldo Giudice, Carmela Tebala, Maria Antonietta Mazzei, Salvatore Cappabianca, Pierosandro Tagliaferri, Grazia Calabrese, Valerio Nardone, Vito Barbieri, Luigi Pirtoli, Salvatore Francesco Carbone, Michele Caraglia, Pierfrancesco Tassone, Alfonso Reginelli, Paolo Tini, Rosanna Capasso, Cirino Botta

المساهمون: Nardone V., Tini P., Pastina P., Botta C., Reginelli A., Carbone S.F., Giannicola R., Calabrese G., Tebala C., Guida C., Giudice A., Barbieri V., Tassone P., Tagliaferri P., Cappabianca S., Capasso R., Luce A., Caraglia M., Mazzei M.A., Pirtoli L., Correale P., Nardone, V., Tini, P., Pastina, P., Botta, C., Reginelli, A., Carbone, S. F., Giannicola, R., Calabrese, G., Tebala, C., Guida, C., Giudice, A., Barbieri, V., Tassone, P., Tagliaferri, P., Cappabianca, S., Capasso, R., Luce, A., Caraglia, M., Mazzei, M. A., Pirtoli, L., Correale, P.

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Survival, Immunology, 03 medical and health sciences, 0302 clinical medicine, Non-small cell lung cancer, Internal medicine, medicine, Progression-free survival, Lung cancer, Pathological, Programmed cell death protein 1, business.industry, Melanoma, Retrospective cohort study, Articles, medicine.disease, Blockade, 030104 developmental biology, Nivolumab, Texture analysis, 030220 oncology & carcinogenesis, Radiomic, business, Kidney cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3c21ad481ff12ec2f56be93eb1d757bTest
http://hdl.handle.net/10447/513588Test

المؤلفون: Antonia Consuelo Falzea, Valerio Nardone, Rocco Giannicola, Vito Barbieri, Nicoletta Staropoli, Graziella Calabrese, Graziella D'Arrigo, Marika Monoriti, Cirino Botta, Pierfrancesco Tassone, Pierosandro Tagliaferri, Pietro Del Medico, Pierpaolo Correale, Giovanni Tripepi, Pierpaolo Pastina, Teresa Del Giudice, Rita Agostino, Luigi Pirtoli

المساهمون: Giannicola R., D'arrigo G., Botta C., Agostino R., Del Medico P., Falzea A.C., Barbieri V., Staropoli N., Del Giudice T., Pastina P., Nardone V., Monoriti M., Calabrese G., Tripepi G., Pirtoli L., Tassone P., Tagliaferri P., Correale P., Giannicola, R, D'Arrigo, G, Botta, C, Agostino, R, Del Medico, P, Falzea, Ac, Barbieri, V, Staropoli, N, Del Giudice, T, Pastina, P, Nardone, V, Monoriti, M, Calabrese, G, Tripepi, G, Pirtoli, L, Tassone, P, Tagliaferri, P, Correale, P

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, IrAE, Extractable nuclear antigens, medicine.medical_treatment, Salvage therapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Lung cancer, Adverse effect, MNSCLC, Chemotherapy, Auto-antibodie, PD-1/PDL-1-blockade, business.industry, Hazard ratio, Cancer, Articles, medicine.disease, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Nivolumab, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ea65fae89e1e2a8e0f0281ab68e9397Test
http://hdl.handle.net/10447/512790Test